Amide and urea derivatives of the formula I <?in-line-formulae description='In-line Formulae' end='lead'?>R<SUP>1</SUP>-(CH<SUB>2</SUB>)<SUB>n</SUB>-(Y)<SUB>q</SUB>-(Z)<SUB>r</SUB>-CO-NH-R<SUP>2 </SUP> (I) <?in-line-formulae description='In-line Formulae' end='tail'?> in which R<SUP>1</SUP>, n, Y, q, Z, r and R<SUP>2 </SUP>have the meanings indicated in claim 1, are potent 5-HT<SUB>1B/1D </SUB>antagonists and exhibit 5-HT reuptake-inhibiting actions and are suitable for the treatment and prophylaxis of anxiety states, depressions, schizophrenia, compulsive ideas, tardive dyskinesias, learning disorders, age-dependent memory disorders, for positively affecting obsessive-compulsive behaviour (OCD), and also for the treatment and for the control of the sequelae of cerebral infarcts such as stroke and cerebral ischaemias.
Amide and urea derivatives as 5-HT reuptake inhibitors and as 5-HT 1B/1D ligands